Many faces of neurosarcoidosis: from chronic meningitis to myelopathy
Drs. D. Fritz, Drs. M. Voortman, Prof. dr. D. van de Beek, Prof. dr. M. Drent, Dr. M.C. Brouwer
This article gives a nice overview of our current knowledge on the clinical presentation, diagnostics, treatment and outcome of patients with neurosarcoidosis, based on international literature. We collaborated with the Antonius hospital in Nieuwegein.
How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?: Making the right clinical decisions for rare diseases with the right tools.
Anne Musters en Sander W. Tas
This article is an editorial in the scientific journal 'Rheumatology'. Evaluating the effects and safety of modern treatment agents which treat rare diseases can be complex, because it can be difficult to properly investigate them in a qualitative clinical trial due to the low number of patients with this disease. Therefore, it is important to adequately describe the effects of these treatments. This article suggests the five domains of the 'Rare IMID Disease Activity Score' (RIDAS).